[November 27, 2015]

Research and Markets: European Molecular Blood Typing, Grouping and Infectious Disease NAT Market 2015

Research and Markets (http://www.researchandmarkets.com/research/z6mr22/2015_european) has announced the addition of the "2015 European Molecular Blood Typing, Grouping and Infectious Disease NAT Market report to their offering.

This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the European molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.

Scope of the Report:

• Explores future marketing and technological trends in major European countries (France, Germany, Italy, Spain, UK)
• Provides test volume and sales forecasts by market segment/test location
• Compares features of major automated and semi-automated molecular and immunohematology analyzers
  
• Profiles eading and emerging competitors
• Identifies specific product and market opportunities facing suppliers during the next five years.
  
  
  
  

Sales and Market Share Analysis:

• Sales and market share estimates for leading suppliers of blood typing, grouping and infectious disease screening tests by country and individual product.
  

Strategic assessments of major suppliers and emerging market entrants, including their:

• Sales
• M&A
• Product portfolios
• Marketing tactics
• New products in R&D.
  

Market Segmentation Analysis:

• Market dynamics
• Trends
• Structure
• Size
• Growth
• Key suppliers
  

Current and Emerging Products:

• Analysis of current and emerging molecular blood typing, grouping and infectious disease NAT screening assays.
• Review of automated and semi-automated molecular and immunohematology analyzers.
  

Technology Review:

• Assessment of current and emerging technologies, and their potential applications for the blood banking market.
• Comprehensive lists of companies developing or marketing new technologies and products, by test.
  

Strategic Recommendations:

• New product development opportunities for molecular blood typing, grouping and infectious disease NAT assays and instrumentation with significant market appeal.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.
  

For more information visit http://www.researchandmarkets.com/research/z6mr22/2015_european

View source version on businesswire.com: http://www.businesswire.com/news/home/20151127005127/en/

[ Back To TMCnet.com's Homepage ]